DCG Group
Biotechnology
Found in 2014, Jiangsu MPM Biotechnology Ltd. is specialized in the R&D, production and sales of modified hydroxypropyl starch (HPS) and its capsules products. In 2016, we obtained a patent from The China National Intellectual Property Administration (CNIPA) for our technology, namely “A modified hydroxypropyl starch and the related preparation methods, a plant-based hollow capsule and its preparation method” (ZL201510046531.9). Our patented hydroxypropyl starch is unique and can yield great quality of capsules being produced in the subsequent process.
We have finished nearly 100 batches of products in our lab in Dongguan, and the final products were successfully produced on the production equipment of different capsule factories, and were awarded inspection certificates by Guangdong Qiangji Pharmaceutical and Taizhou Food and Drug Inspection Bureau. The test results of capsules made from our products meet the quality indicators such as uniformity, transparency, tightness, friability, disintegration time and loss on drying as outlined in the Chinese Pharmacopoeia (2015). In 2019, we began setting up a manufacturing facility with an annual production capacity of 1,000 tonnes in the China Medical City (CMC) in Taizhou, Jiangsu. Production will begin in early 2021.
Jiangsu Address:
3/F., the Complex Building North Wing,
Binjiang Pharmaceutical Product Public Service Platforms,
Gaogang District,
Taizhou, Jiangsu, China
Tel: (86) 523-8666-2282
Fax: (86) 523-8568-0607
Hong Kong Address:
Unit M2, M/F, Sun Cheong Building,
2 Cheung Yee St.,
Lai Chi Kok, Kowloon, HK
Tel: (852) 2251-5519
Fax: (852) 2785 0953
Email: www.china2hk.com
